Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii).

Patchett AL, Coorens THH, Darby J, Wilson R, McKay MJ, Kamath KS, Rubin A, Wakefield M, Mcintosh L, Mangiola S, Pye RJ, Flies AS, Corcoran LM, Lyons AB, Woods GM, Murchison EP, Papenfuss AT, Tovar C.

Cell Mol Life Sci. 2019 Aug 2. doi: 10.1007/s00018-019-03259-2. [Epub ahead of print]

PMID:
31375869
2.

Somatic evolution and global expansion of an ancient transmissible cancer lineage.

Baez-Ortega A, Gori K, Strakova A, Allen JL, Allum KM, Bansse-Issa L, Bhutia TN, Bisson JL, Briceño C, Castillo Domracheva A, Corrigan AM, Cran HR, Crawford JT, Davis E, de Castro KF, B de Nardi A, de Vos AP, Delgadillo Keenan L, Donelan EM, Espinoza Huerta AR, Faramade IA, Fazil M, Fotopoulou E, Fruean SN, Gallardo-Arrieta F, Glebova O, Gouletsou PG, Häfelin Manrique RF, Henriques JJGP, Horta RS, Ignatenko N, Kane Y, King C, Koenig D, Krupa A, Kruzeniski SJ, Kwon YM, Lanza-Perea M, Lazyan M, Lopez Quintana AM, Losfelt T, Marino G, Martínez Castañeda S, Martínez-López MF, Meyer M, Migneco EJ, Nakanwagi B, Neal KB, Neunzig W, Ní Leathlobhair M, Nixon SJ, Ortega-Pacheco A, Pedraza-Ordoñez F, Peleteiro MC, Polak K, Pye RJ, Reece JF, Rojas Gutierrez J, Sadia H, Schmeling SK, Shamanova O, Sherlock AG, Stammnitz M, Steenland-Smit AE, Svitich A, Tapia Martínez LJ, Thoya Ngoka I, Torres CG, Tudor EM, van der Wel MG, Viţălaru BA, Vural SA, Walkinton O, Wang J, Wehrle-Martinez AS, Widdowson SAE, Stratton MR, Alexandrov LB, Martincorena I, Murchison EP.

Science. 2019 Aug 2;365(6452). pii: eaau9923. doi: 10.1126/science.aau9923.

PMID:
31371581
3.

Tasman-PCR: a genetic diagnostic assay for Tasmanian devil facial tumour diseases.

Kwon YM, Stammnitz MR, Wang J, Swift K, Knowles GW, Pye RJ, Kreiss A, Peck S, Fox S, Pemberton D, Jones ME, Hamede R, Murchison EP.

R Soc Open Sci. 2018 Oct 3;5(10):180870. doi: 10.1098/rsos.180870. eCollection 2018 Oct.

4.

The Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian Devils.

Stammnitz MR, Coorens THH, Gori KC, Hayes D, Fu B, Wang J, Martin-Herranz DE, Alexandrov LB, Baez-Ortega A, Barthorpe S, Beck A, Giordano F, Knowles GW, Kwon YM, Hall G, Price S, Pye RJ, Tubio JMC, Siddle HVT, Sohal SS, Woods GM, McDermott U, Yang F, Garnett MJ, Ning Z, Murchison EP.

Cancer Cell. 2018 Apr 9;33(4):607-619.e15. doi: 10.1016/j.ccell.2018.03.013.

5.

Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils.

Tovar C, Pye RJ, Kreiss A, Cheng Y, Brown GK, Darby J, Malley RC, Siddle HV, Skjødt K, Kaufman J, Silva A, Baz Morelli A, Papenfuss AT, Corcoran LM, Murphy JM, Pearse MJ, Belov K, Lyons AB, Woods GM.

Sci Rep. 2017 Mar 9;7:43827. doi: 10.1038/srep43827.

6.

Mitochondrial genetic diversity, selection and recombination in a canine transmissible cancer.

Strakova A, Ní Leathlobhair M, Wang GD, Yin TT, Airikkala-Otter I, Allen JL, Allum KM, Bansse-Issa L, Bisson JL, Castillo Domracheva A, de Castro KF, Corrigan AM, Cran HR, Crawford JT, Cutter SM, Delgadillo Keenan L, Donelan EM, Faramade IA, Flores Reynoso E, Fotopoulou E, Fruean SN, Gallardo-Arrieta F, Glebova O, Häfelin Manrique RF, Henriques JJ, Ignatenko N, Koenig D, Lanza-Perea M, Lobetti R, Lopez Quintana AM, Losfelt T, Marino G, Martincorena I, Martínez Castañeda S, Martínez-López MF, Meyer M, Nakanwagi B, De Nardi AB, Neunzig W, Nixon SJ, Onsare MM, Ortega-Pacheco A, Peleteiro MC, Pye RJ, Reece JF, Rojas Gutierrez J, Sadia H, Schmeling SK, Shamanova O, Ssuna RK, Steenland-Smit AE, Svitich A, Thoya Ngoka I, Vițălaru BA, de Vos AP, de Vos JP, Walkinton O, Wedge DC, Wehrle-Martinez AS, van der Wel MG, Widdowson SA, Murchison EP.

Elife. 2016 May 17;5. pii: e14552. doi: 10.7554/eLife.14552.

7.

A second transmissible cancer in Tasmanian devils.

Pye RJ, Pemberton D, Tovar C, Tubio JM, Dun KA, Fox S, Darby J, Hayes D, Knowles GW, Kreiss A, Siddle HV, Swift K, Lyons AB, Murchison EP, Woods GM.

Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):374-9. doi: 10.1073/pnas.1519691113. Epub 2015 Dec 28.

8.

Devil Facial Tumor Disease.

Pye RJ, Woods GM, Kreiss A.

Vet Pathol. 2016 Jul;53(4):726-36. doi: 10.1177/0300985815616444. Epub 2015 Dec 13. Review.

PMID:
26657222
9.

Discovery and SAR of 2-arylbenzotriazoles and 2-arylindazoles as potential treatments for Duchenne muscular dystrophy.

De Moor O, Dorgan CR, Johnson PD, Lambert AG, Lecci C, Maillol C, Nugent G, Poignant SD, Price PD, Pye RJ, Storer R, Tinsley JM, Vickers R, Well Rv, Wilkes FJ, Wilson FX, Wren SP, Wynne GM.

Bioorg Med Chem Lett. 2011 Aug 15;21(16):4828-31. doi: 10.1016/j.bmcl.2011.06.047. Epub 2011 Jun 17.

PMID:
21741236
10.

Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy.

Chancellor DR, Davies KE, De Moor O, Dorgan CR, Johnson PD, Lambert AG, Lawrence D, Lecci C, Maillol C, Middleton PJ, Nugent G, Poignant SD, Potter AC, Price PD, Pye RJ, Storer R, Tinsley JM, van Well R, Vickers R, Vile J, Wilkes FJ, Wilson FX, Wren SP, Wynne GM.

J Med Chem. 2011 May 12;54(9):3241-50. doi: 10.1021/jm200135z. Epub 2011 Apr 15.

PMID:
21456623
11.

Terahertz pulsed spectroscopy of human Basal cell carcinoma.

Wallace VP, Fitzgerald AJ, Pickwell E, Pye RJ, Taday PF, Flanagan N, Ha T.

Appl Spectrosc. 2006 Oct;60(10):1127-33.

PMID:
17059664
12.

Terahertz pulsed imaging of human breast tumors.

Fitzgerald AJ, Wallace VP, Jimenez-Linan M, Bobrow L, Pye RJ, Purushotham AD, Arnone DD.

Radiology. 2006 May;239(2):533-40. Epub 2006 Mar 16.

PMID:
16543586
13.

Simulating the response of terahertz radiation to basal cell carcinoma using ex vivo spectroscopy measurements.

Pickwell E, Fitzgerald AJ, Cole BE, Taday PF, Pye RJ, Ha T, Pepper M, Wallace VP.

J Biomed Opt. 2005 Nov-Dec;10(6):064021.

14.

Concise and enantioselective synthesis of the aminocyclitol core of hygromycin A.

Donohoe TJ, Johnson PD, Pye RJ, Keenan M.

Org Lett. 2005 Mar 31;7(7):1275-7.

PMID:
15787485
15.

Efficient acyclic stereocontrol using the tethered aminohydroxylation reaction.

Donohoe TJ, Johnson PD, Pye RJ, Keenan M.

Org Lett. 2004 Jul 22;6(15):2583-5.

PMID:
15255696
16.

Terahertz pulsed imaging and spectroscopy for biomedical and pharmaceutical applications.

Wallace VP, Taday PF, Fitzgerald AJ, Woodward RM, Cluff J, Pye RJ, Arnone DD.

Faraday Discuss. 2004;126:255-63; discussion 303-11.

PMID:
14992411
17.

The tethered aminohydroxylation (TA) reaction.

Donohoe TJ, Johnson PD, Pye RJ.

Org Biomol Chem. 2003 Jun 21;1(12):2025-8.

PMID:
12945888
18.

Terahertz pulse imaging of ex vivo basal cell carcinoma.

Woodward RM, Wallace VP, Pye RJ, Cole BE, Arnone DD, Linfield EH, Pepper M.

J Invest Dermatol. 2003 Jan;120(1):72-8.

19.

Terahertz pulse imaging in reflection geometry of human skin cancer and skin tissue.

Woodward RM, Cole BE, Wallace VP, Pye RJ, Arnone DD, Linfield EH, Pepper M.

Phys Med Biol. 2002 Nov 7;47(21):3853-63. Review.

PMID:
12452577
20.

Surgical Pearl: The "skin strip" method for harvesting tissue to graft chronic ulceration.

Woodrow SL, Mehta RK, Pye RJ.

J Am Acad Dermatol. 2002 Oct;47(4):600-1. No abstract available.

PMID:
12271306
21.

The pustular eruption of ulcerative colitis: reply

Sarkany RP, Burrows NP, Grant JW, Pye RJ, Norris PG.

Br J Dermatol. 1998 Oct;139(4):758-9. No abstract available.

PMID:
9893207
22.

The pustular eruption of ulcerative colitis: a variant of Sweet's syndrome?

Sarkany RP, Burrows NP, Grant JW, Pye RJ, Norris PG.

Br J Dermatol. 1998 Feb;138(2):365-6. No abstract available.

PMID:
9602899
23.

Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.

Isaacs JD, Burrows N, Wing M, Keogan MT, Rebello PR, Watts RA, Pye RJ, Norris P, Hazelman BL, Hale G, Waldmann H.

Clin Exp Immunol. 1997 Nov;110(2):158-66.

24.

Progressive granulomatous resection to Bacille Calmette-Guérin (BCG) vaccination.

Pye RJ.

Clin Exp Dermatol. 1997 Mar;22(2):109-10. No abstract available.

PMID:
9330080
25.

Keratinocyte culture.

Barlow Y, Pye RJ.

Methods Mol Biol. 1997;75:117-29. Review. No abstract available.

PMID:
9276264
26.

Extramammary Paget's disease.

Burrows NP, Pye RJ.

Acta Derm Venereol. 1997 Jan;77(1):78. No abstract available.

27.

Treatment of extramammary Paget's disease by radiotherapy.

Burrows NP, Jones DH, Hudson PM, Pye RJ.

Br J Dermatol. 1995 Jun;132(6):970-2.

PMID:
7662577
28.

Mid-dermal elastolysis.

Sterling JC, Coleman N, Pye RJ.

Br J Dermatol. 1994 Apr;130(4):502-6. Review.

PMID:
8186118
29.

Osteoma cutis as a sequela of acne.

Ratnavel RC, Burrows NP, Pye RJ.

J R Soc Med. 1994 Feb;87(2):107-8. No abstract available.

30.

Scleroderma and the carcinoid syndrome.

Ratnavel RC, Burrows NP, Pye RJ.

Clin Exp Dermatol. 1994 Jan;19(1):83-5. Review.

PMID:
8313648
31.

Auricular embryonal rhabdomyosarcoma.

Burrows NP, Ratnavel RC, Grant JW, Cormack GC, Pye RJ.

Dermatology. 1994;189(3):301-3.

PMID:
7949490
32.

The urticarias 1990.

Kobza Black A, Greaves MW, Champion RH, Pye RJ.

Br J Dermatol. 1991 Jan;124(1):100-8. No abstract available.

PMID:
1993134
33.

Recognition of two distinct major antigens by bullous pemphigoid sera.

Cook AL, Hanahoe TH, Mallett RB, Pye RJ.

Br J Dermatol. 1990 Apr;122(4):435-44.

PMID:
1692473
34.

Keratinocyte culture.

Barlow Y, Pye RJ.

Methods Mol Biol. 1990;5:83-97. doi: 10.1385/0-89603-150-0:83.

PMID:
21374118
35.

Binding of bullous pemphigoid and pemphigus vulgaris sera to SCaBER cell line in an ELISA.

Cook AL, Mallett RB, Hanahoe TH, Pye RJ.

Br J Dermatol. 1989 Jan;120(1):59-69.

PMID:
2700665
36.

Erosive pustular dermatosis of the scalp--a definition.

Burton JL, Peachey RD, Pye RJ.

Br J Dermatol. 1988 Sep;119(3):411. No abstract available.

PMID:
3179216
37.

Cultured keratinocytes as biological wound dressings.

Pye RJ.

Eye (Lond). 1988;2 ( Pt 2):172-8.

PMID:
2461880
38.

Naproxen-induced pseudoporphyria.

Sterling JC, Pye RJ.

Br J Rheumatol. 1987 Jun;26(3):210-1. No abstract available.

PMID:
3580714
39.
40.

The detection of pemphigoid-like antigens on the surface of SCaBER cells.

Cook AL, Pye RJ.

Br J Dermatol. 1985 Dec;113(6):798-800. No abstract available.

PMID:
3913460
41.

Seborrhoea is not a feature of seborrhoeic dermatitis.

Burton JL, Pye RJ.

Br Med J (Clin Res Ed). 1983 Apr 9;286(6372):1169-70.

42.

Double blind comparison of the efficacy of tioconazole and miconazole for the treatment of fungal infection of the skin or erythrasma.

Clayton YM, Hay RJ, McGibbon DH, Pye RJ.

Clin Exp Dermatol. 1982 Sep;7(5):543-9. No abstract available.

PMID:
6756715
43.

Prospects for the treatment of acne vulgaris and rosacea.

Pye RJ.

Clin Exp Dermatol. 1982 Mar;7(2):195-200. No abstract available.

PMID:
6211304
44.

Benign rheumatoid nodules of the skin.

Pye RJ, Greaves MW.

Br J Dermatol. 1979 Jul;101 Suppl 17:58-9. No abstract available.

PMID:
465342
45.

Erosive pustular dermatosis of the scalp.

Pye RJ, Peachey RD, Burton JL.

Br J Dermatol. 1979 May;100(5):559-66.

PMID:
444428
46.

BCG abscess a complication of jet injector vaccination.

Marston JA, Pye RJ.

Practitioner. 1978 Apr;220(1318):625-6. No abstract available.

PMID:
656189
47.

Effect of oral contraceptives on sebum excretion rate.

Pye RJ, Meyrick G, Pye MJ, Burton JL.

Br Med J. 1977 Dec 17;2(6102):1581-2.

48.

Free fatty acids in the early inflammatory papule of acne vulgaris.

Pye RJ, Meyrick G, Burton JL.

Clin Exp Dermatol. 1977 Dec;2(4):355-9. No abstract available.

PMID:
146579
49.

Phenothiazine therapy and plasma immunoreactive beta-MSH in schizophrenia and pruritic dermatoses.

Smith AG, Goolamali SK, Thody AJ, Shuster S, Pye RJ, Burton JL.

Br J Dermatol. 1977 May;96(5):537-9.

PMID:
871390
50.

Bullous pyoderma as a presentation of acute leukaemia.

Pye RJ, Choundhury C.

Clin Exp Dermatol. 1977 Mar;2(1):33-8. No abstract available.

PMID:
324664

Supplemental Content

Support Center